Evidence map›Paper›PMID 38830763›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2024

Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Ceruleus Degeneration, and Hippocampal Amyloid-β

Kathy Zhang, Yan Zhu, Polina Fenik, Dennis Fleysh, Colin Ly, Steven A Thomas, Sigrid Veasey

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kathy ZhangDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Yan ZhuDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Polina FenikDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Dennis FleyshDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Colin LyDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Steven A ThomasDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Sigrid VeaseyDepartments of Medicine and Pharmacology, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 veasey@mail.med.upenn.edu.

Funding

Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer DiseaseR01AG064231 · NIA · UNIVERSITY OF PENNSYLVANIA · PI NAIDOO, NIRMALA NIRINJINI, VEASEY, SIGRID C · 2020 to 2024
$3.7M
Short Sleep: Locus Coeruleus Metabolics and the Temporal Progression of AlzheimersRF1AG054104 · NIA · UNIVERSITY OF PENNSYLVANIA · PI VEASEY, SIGRID C · 2016 to 2016
$3.1M
Catecholaminergic Signaling in Normal Cognition, Aging and Models of Alzheimer's DiseaseR01AG066905 · NIA · UNIVERSITY OF PENNSYLVANIA · PI THOMAS, STEVEN A · 2024 to 2024
$620k
NIA NIH HHS R01 AG064231NIA NIH HHS R01 AG066905NIA NIH HHS RF1 AG054104
6 · The paper itself

Abstract

Chronic sleep disruption (CSD), from insufficient or fragmented sleep and is an important risk factor for Alzheimer's disease (AD). Underlying mechanisms are not understood. CSD in mice results in degeneration of locus ceruleus neurons (LCn) and CA1 hippocampal neurons and increases hippocampal amyloid-β

Indexed as

Amyloid beta-PeptidesCysteine EndopeptidasesHippocampusLocus CoeruleusNorepinephrineSleep DeprivationAnimalsAsparaginyl EndopeptidaseDopamine beta-HydroxylaseFemaleMaleMiceMice, Inbred C57BLMice, KnockoutNerve DegenerationPeptide FragmentsAmyloid beta-Peptidesamyloid beta-protein (1-42)Asparaginyl EndopeptidaseCysteine EndopeptidasesDopamine beta-HydroxylaseNorepinephrinePeptide Fragmentstau Proteinsamyloidhippocampuslocus ceruleusnorepinephrinesleep deprivationtau

Identifiers

PMID38830763
PMCPMC11236578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.